Using Medical Cannabis in an Oncology Practice. Read more about Using Medical Cannabis in an Oncology Practice.
The double-edged sword of ADT: emerging evidence of cardiovascular, pulmonary, and renal risks. Read more about The double-edged sword of ADT: emerging evidence of cardiovascular, pulmonary, and renal risks.
ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer. Read more about ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.
Small-cell/neuroendocrine prostate cancer: a growing threat? Read more about Small-cell/neuroendocrine prostate cancer: a growing threat?
The current clinical value of the DCIS Score. Read more about The current clinical value of the DCIS Score.
Radium-223 vs EBRT for multiple painful bone metastases: is less more? Read more about Radium-223 vs EBRT for multiple painful bone metastases: is less more?
Expanding options for pancreatic cancer... so where do we go from here? Read more about Expanding options for pancreatic cancer... so where do we go from here?
Peripheral neuropathy experience in patients with relapsed and/or refractory multiple myeloma treated with carfilzomib. Read more about Peripheral neuropathy experience in patients with relapsed and/or refractory multiple myeloma treated with carfilzomib.
Biomarkers in colon cancer: the chasm between expectations and reality. Read more about Biomarkers in colon cancer: the chasm between expectations and reality.
Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management. Read more about Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.
